NCT00676039View on ClinicalTrials.gov

Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Healthy
Interventions
DRUG

Venlafaxine

NOVO-Venlafaxine XR 75 mg (NOVOPHARM, Generic)

DRUG

Gen-Citalopram

Gen-Citalopram 40 mg (Genpharm, Generic)

DRUG

Effexor XR

Effexor XR 75 mg (Wyeth Pharmaceuticals, Brand Name)

DRUG

Celexa

Celexa 40 mg (Lundbeck, Brand Name)

Trial Locations (1)

K1Z7K4

University of Ottawa, Institute of Mental Health Research, Ottawa

All Listed Sponsors
lead

University of Ottawa

OTHER

NCT00676039 - Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations | Biotech Hunter | Biotech Hunter